Ngā hua rapu - Tong‐Ming Fu
- E whakaatu ana i te 1 - 20 hua o te 39
- Haere ki te Whārangi Whai Ake
-
1
-
2
Natural killer cells in cancer biology and therapy mā Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, Zhi-Ming Shao
I whakaputaina 2020Revisão -
3
Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization mā Tong‐Ming Fu, Arthur Friedman, Jeffrey B. Ulmer, M A Liu, John Donnelly
I whakaputaina 1997Artigo -
4
-
5
Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge mā Tong‐Ming Fu, Liming Guan, Arthur Friedman, Timothy Schofield, Jeffrey B. Ulmer, Margaret A. Liu, John Donnelly
I whakaputaina 1999Artigo -
6
-
7
Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity mā Joseph E. Blaney, Eri Nobusawa, Michael A. Brehm, Robert H. Bonneau, Lawrence M. Mylin, Tong‐Ming Fu, Yoshihiro Kawaoka, Satvir S. Tevethia
I whakaputaina 1998Artigo -
8
Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1–Exposed Infants mā Kristy M. Bialas, Daniel Westreich, Eduardo Cisneros de la Rosa, Cody S. Nelson, Lawrence M. Kauvar, Tong‐Ming Fu, Sallie R. Permar
I whakaputaina 2016Artigo -
9
Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells mā Xiaohong Cui, Daniel C. Freed, Dai Wang, Ping Qiu, Fengsheng Li, Tong‐Ming Fu, Lawrence M. Kauvar, Michael A. McVoy
I whakaputaina 2017Artigo -
10
Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes mā Tong‐Ming Fu, Jeffrey B. Ulmer, Michael J. Caulfield, R. Randall Deck, Arthur Friedman, Su Wang, Xu Liu, John Donnelly, Margaret A. Liu, Hans Wigzell
I whakaputaina 1997Artigo -
11
Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine mā Rebecca T. Emeny, Cosette M. Wheeler, Kathrin U. Jansen, William C. Hunt, Tong‐Ming Fu, Judith F. Smith, Stefani A. MacMullen, Mark T. Esser, Xavier Paliard
I whakaputaina 2002Artigo -
12
Putative Immunodominant Human Immunodeficiency Virus-Specific CD8<sup>+</sup>T-Cell Responses Cannot Be Predicted by Major Histocompatibility Complex Class I Haplotype mā Michael R. Betts, Joseph P. Casazza, Brent A. Patterson, Shar L. Waldrop, Wendy L. Trigona, Tong‐Ming Fu, Florian Kern, Louis J. Picker, Richard A. Koup
I whakaputaina 2000Artigo -
13
Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus mā Tong‐Ming Fu, Daniel C. Freed, Melanie Horton, Fan Jiang, Michael Citron, Joseph G. Joyce, Victor M. Garsky, Danilo R. Casimiro, Qinjian Zhao, John W. Shiver, Xiaoping Liang
I whakaputaina 2008Artigo -
14
Protective CD4<sup>+</sup>and CD8<sup>+</sup>T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA mā Jeffrey B. Ulmer, Tong‐Ming Fu, R. Randall Deck, Arthur Friedman, Liming Guan, Corrille M. DeWitt, Xu Liu, Su Wang, Margaret A. Liu, John Donnelly, Michael J. Caulfield
I whakaputaina 1998Artigo -
15
Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans mā Jennifer A. Jenks, Cody S. Nelson, Hunter Roark, Matthew L. Goodwin, Robert F. Pass, David I. Bernstein, Emmanuel B. Walter, Kathryn M. Edwards, Dai Wang, Tong‐Ming Fu, Zhiqiang An, Cliburn Chan, Sallie R. Permar
I whakaputaina 2020Artigo -
16
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination mā Fengsheng Li, Daniel C. Freed, Aimin Tang, Richard R. Rustandi, Matthew C. Troutman, Amy S. Espeseth, Ningyan Zhang, Zhiqiang An, Michael A. McVoy, Hua Zhu, Sha Ha, Dai Wang, Stuart P. Adler, Tong‐Ming Fu
I whakaputaina 2017Artigo -
17
A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaque... mā Stefania Capone, Annalisa Meola, Bruno Bruni Ercole, Alessandra Vitelli, Monica Pezzanera, Lionello Ruggeri, M E Davies, Rosalba Tafi, Claudia Santini, Alessandra Luzzago, Tong‐Ming Fu, Andrew Bett, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia, Antonella Folgori
I whakaputaina 2006Artigo -
18
Simian Immunodeficiency Virus (SIV)<i>gag</i>DNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Inf... mā Michael A. Egan, William A. Charini, Marcelo J. Kuroda, Jörn E. Schmitz, Paul Rácz, Klara Tenner‐Racz, Kelledy Manson, Michael S. Wyand, Michelle A. Lifton, Christie E. Nickerson, Tong‐Ming Fu, John W. Shiver, Norman L. Letvin
I whakaputaina 2000Artigo -
19
Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors mā Danilo R. Casimiro, Andrew J. Bett, Tong‐Ming Fu, Mary-Ellen Davies, Aimin Tang, Keith A. Wilson, Minchun Chen, Romnie Long, Troy W. McKelvey, Michael Chastain, Sanjay Gurunathan, Jim Tartaglia, Emilio A. Emini, John W. Shiver
I whakaputaina 2004Artigo -
20
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects mā Stuart P. Adler, Nicole Lewis, Anthony Conlon, Mark P. Christiansen, Mohamed Al‐Ibrahim, Richard Rupp, Tong‐Ming Fu, Oliver Bautista, Huaping Tang, Dai Wang, A. Fisher, Timothy D. Culp, Rituparna Das, Karen Beck, Gretchen Tamms, Luwy Musey
I whakaputaina 2019Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Immunology
Biology
Virology
Virus
Immune system
Antibody
Genetics
Medicine
Gene
In vitro
Biochemistry
CD8
Cytotoxic T cell
Epitope
Vaccination
Viral disease
CTL*
DNA vaccination
Human cytomegalovirus
Immunity
Immunization
Antigen
Cellular immunity
Neutralizing antibody
Recombinant DNA
Viral replication
Cytomegalovirus
Herpesviridae
Disease
Immunogenicity